肝素抑制PET/CT中心肌生理性FDG摄取有效性的Meta分析
该Meta分析纳入5项随机对照试验共910例患者(肝素组550例、无肝素组360例),比较普通肝素(UFH)与非UFH抑制心肌18F-FDG生理性摄取的效果。总体分析未显示显著差异(OR 2.279,95%CI 0.593–8.755,p=0.23),异质性高(I²=91.16%);固定 fasting 时长亚组中UFH抑制效果有统计学意义(OR 4.452,95%CI 1.221–16.233,p=0.024),可变 fasting 时长亚组无显著效果。作者建议静脉给予UFH可作为抑制心肌FDG摄取的辅助方法。
要点
- 5项RCT共910例,肝素组550例 vs 无肝素组360例,总体心肌FDG抑制无显著差异(OR 2.279,95%CI 0.593–8.755,p=0.23)。
- 固定 fasting 时长亚组中肝素抑制心肌FDG摄取有统计学意义(OR 4.452,95%CI 1.221–16.233,p=0.024)。
- 可变 fasting 时长亚组中肝素未见显著抑制效果。
核心结论
- 作者认为静脉给予普通肝素(UFH)可考虑作为抑制心肌FDG摄取的辅助方法。
研究设计与样本
- 遵循PRISMA指南检索PubMed、Embase、Cochrane图书馆、Web of Knowledge及www.clinicaltrail.gov数据库,检索自最早记录至2023年3月。
- 最终纳入5项随机对照试验(RCT),共910例患者(肝素组550例,无肝素组360例)。
- 采用随机效应模型合并效应量,计算合并比值比(OR),并按固定与可变 fasting 时长进行亚组分析。
主要发现
- 总体分析显示UFH组与非UFH组抑制心肌FDG摄取无显著差异(OR 2.279,95%CI 0.593–8.755,p=0.23),统计学异质性高(I²=91.16%)。
- 固定 fasting 时长亚组中UFH给药对心肌FDG摄取有统计学显著抑制(OR 4.452,95%CI 1.221–16.233,p=0.024)。
- 可变 fasting 时长亚组未显示显著效果。
关键数值与推荐
- 总体合并OR 2.279(95%CI 0.593–8.755,p=0.23),异质性I²=91.16%。
- 固定 fasting 时长亚组合并OR 4.452(95%CI 1.221–16.233,p=0.024)。
临床怎么用
- 作者建议:静脉给予UFH可考虑作为抑制心肌FDG摄取的辅助方法。
局限性
- 总体分析统计学异质性高(I²=91.16%)。
- 可变 fasting 时长亚组未显示显著效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The present meta-analysis aims to investigate the effectiveness of heparin administration in suppressing physiological myocardial 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET)/computed tomography (CT), as its role in this regard has not been well investigated. METHODS: PRISMA guidelines were used to interrogate the PubMed, Embase, Cochrane library, Web of Knowledge, and www.clinicaltrail.gov databases from the earliest records to March 2023. The final analysis included five randomized controlled trials (RCTs). Meta-analysis was conducted to compare the effectiveness of unfractionated heparin (UFH) administration versus non-UFH administration, and subgroup analysis based on fixed and variable fasting durations was conducted. Effect sizes were pooled using a random-effects model, and the pooled odds ratios (ORs) were calculated. RESULTS: Five eligible RCTs with a total of 910 patients (550 with heparin, 360 without heparin) were included. The forest plot analysis initially indicated no significant difference in the suppression of myocardial FDG uptake between the UFH and non-UFH groups (OR 2.279, 95% CI 0.593 to 8.755, p = 0.23), with a high degree of statistical heterogeneity (I2 = 91.16%). Further subgroup analysis showed that the fixed fasting duration group with UFH administration had statistically significant suppression of myocardial FDG uptake (OR 4.452, 95% CI 1.221 to 16.233, p = 0.024), while the varying fasting duration group did not show a significant effect. CONCLUSIONS: According to the findings of our meta-analysis, we suggest that intravenous administration of UFH can be considered as a supplementary approach to suppress myocardial FDG uptake.
引用
- Chan SH, Huang CK, Luzhbin D, et al. Meta-analysis of the effectiveness of heparin in suppressing physiological myocardial FDG uptake in PET/CT. J Nucl Cardiol. 2023. PMID: 37258954. doi:10.1007/s12350-023-03296-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。